Reply to the Editor  by Hornik, Lech
association between the Symmetry and
proximal graft failure. My concern is in the
wider area of dissemination and adoption
of new technologies. Without statements
on data limitations, publication of biased
noncomparative data on any new technol-
ogy is potentially alarmist (or overoptimis-
tic), may prevent proper evaluation and
development, and may unnecessarily
hinder (or accelerate) uptake of new tech-
nologies, some of which could be poten-
tially beneficial (or harmful). Authors of
reports on new technologies should list
limitations and highlight any confounding
factors or alternative explanations for ad-
verse events (or benefits); otherwise read-
ers could be inadvertently misinformed.
Ani C. Anyanwu, FRCS
Cardiac Surgical Unit, Harefield Hospital
Middlesex, United Kingdom
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Reply to the Editor:
I thank Mr Anyanwu for his interesting
remarks.
I agree with the statement of Mr An-
yanwu concerning the use of the internal
thoracic arteries in coronary artery bypass
grafting. I used to follow the same strategy
and prefer extended utilization of the left
internal thoracic artery as a graft especially,
for the left anterior descending (LAD)
and/or diagonal branches. We accept it as
graft source irrespective of patient age, so
that in about 92% to 95% of the patients the
left internal thoracic artery is placed in the
LAD area, although the average patient age
is around 72 years old. I decided intention-
ally to make an exception to this strategy as
I wanted to gain intensive experience with
the new technology in creating the proxi-
mal vein graft anastomosis within a short
period of time, so that mostly no internal
thoracic arteries were used in the men-
tioned patient group unless the vein quality
was inadequate.
Although in this series the first use of
the anastomotic device took place on April
30, 2001, and the last one on October 22,
2001, of these 45 reported patients, 35 were
operated on in the relatively short period of
time from June 1 to July 5, 2001.
I agree that the calcified ascending aorta
implies the utilization of the pedicled inter-
nal thoracic arteries. However, I often
place many grafts in multimorbid octoge-
narians with more or less calcified ascend-
ing aortae, and I am forced to at least
partial use of vein grafts. I try then to find
the most suitable site for the proximal anas-
tomosis, regardless whether the given anas-
tomosis is hand-sewn in the conventional
way or performed by use of any anasto-
motic device. I have never faced results
like these until now. In very heavily calci-
fied ascending aortae, both techniques are
expected to fail; if at all possible the aorta
should be replaced.
For the same reason of gaining experi-
ence with off-pump techniques within this
period of time, accepted coronary patients
were primarily declared for off-pump pro-
cedure without any preselection (ie, regard-
less of coronary morphology and other rel-
evant factors).
I used to make the final decision to
proceed or not with the off-pump technique
at the very beginning of the surgery, mak-
ing it dependent on the feasibility of this
technique, so that many patients were
switched to on-pump without making any
effort to follow the off-pump strategy. I
converted to on-pump quite liberally for 2
reasons. First, I am generally not convinced
of the superiority of the off-pump tech-
niques; second, I often face an extremely
bad coronary morphology and/or bad ejec-
tion fraction. I mean the borderline cases in
whom the feasibility of coronary artery by-
pass grafting is generally problematic.
With those patients, we try to proceed with
the conventional bypass surgery before we
are forced to use any form of an end-stage
therapy (ie, heart transplantation, implanta-
tion of an assist device for recovery, for
bridging, or as definite surgery). Our heart
center is a leader in utilizing mechanical
circulatory support devices; we success-
fully follow this strategy in patients with
end-stage coronary artery disease for a long
time.
My article is a case report and not a
randomized study; as such, you will find no
comparison with any statistical signifi-
cance. However, the causality between the
utilized technology for creation of the
proximals and the reported complication is
in my opinion quite possible as these com-
plications are an exceptional “on the row”
phenomenon in my practice. I used to per-
form about 350 to 450 isolated coronary
artery bypass grafting procedures each
year; the operative capacity of the entire
heart center is about 5000 cardiac proce-
dures including approximately 3500 iso-
lated coronary artery bypass grafting pro-
cedures yearly. My colleagues and I have
never faced a similar experience. These
were the first graft occlusions or stenoses
that I had to deal with in many years.
I would like to use this opportunity to
report an additional case of severe stenosis
of the proximal vein graft anastomosis cre-
ated with ACS. A 65-year-old man with 1
sequential vein graft to LAD and diagonal
branch placed in off-pump technique using
the ACS developed de novo angina pecto-
ris 6 months after surgery. Angiography
revealed a severe stenosis of the proximal
anastomosis. Very impressive was the ret-
rograde filling of the graft until the ste-
nosed proximal anastomosis. The patient
underwent successful redo surgery; I could
not find any explanation for the event this
time, either. However, I do not claim to
deliver any evidence for or against the uti-
lization of the device. I have highlighted in
my article that the role of the device in the
genesis of the reported complications has
to be cleared.
Lech Hornik, MD, PhD
Department of Thoracic and
Cardiovascular Surgery
Heart Center North Rhine-Wesphalia
Bad Oeynhausen, Germany
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Pattern of lymphatic spread and
prognosis in pN1 non–small cell
lung cancer: What does it stand for?
To the Editor:
We read with great interest the report from
Marra and colleagues1 recently published
in the Journal, and we warmly congratulate
them on their excellent, accurate, and ex-
haustive analysis and report. They have
confirmed that within the pathologic N1
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